Cargando…

Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity

Vaginal laxity (VL) and genitourinary syndrome of menopause (GSM), as well as aesthetic changes in the vulvar skin, often occur together and cause physical, psychological, and functional problems for women and their partners. The current study evaluated the efficacy of a nonsurgical radiofrequency d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolczewski, Piotr, Parafiniuk, Mirosław, Zawodny, Piotr, Haddad, Rashad, Nalewczyńska, Agnieszka, Kolasa, Agnieszka Kinga, Wiszniewska, Barbara, Menkes, Sophie, Bader, Alexander, Stabile, Giorgio, Zerbinati, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788573/
https://www.ncbi.nlm.nih.gov/pubmed/36559022
http://dx.doi.org/10.3390/ph15121571
_version_ 1784858786708586496
author Kolczewski, Piotr
Parafiniuk, Mirosław
Zawodny, Piotr
Haddad, Rashad
Nalewczyńska, Agnieszka
Kolasa, Agnieszka Kinga
Wiszniewska, Barbara
Menkes, Sophie
Bader, Alexander
Stabile, Giorgio
Zerbinati, Nicola
author_facet Kolczewski, Piotr
Parafiniuk, Mirosław
Zawodny, Piotr
Haddad, Rashad
Nalewczyńska, Agnieszka
Kolasa, Agnieszka Kinga
Wiszniewska, Barbara
Menkes, Sophie
Bader, Alexander
Stabile, Giorgio
Zerbinati, Nicola
author_sort Kolczewski, Piotr
collection PubMed
description Vaginal laxity (VL) and genitourinary syndrome of menopause (GSM), as well as aesthetic changes in the vulvar skin, often occur together and cause physical, psychological, and functional problems for women and their partners. The current study evaluated the efficacy of a nonsurgical radiofrequency device (RF) procedure combined with hyaluronic acid (HA) injection into the skin of the labia majora on clinical, histological, and aesthetic levels. Twenty women with GSM and VL, aged between 36 and 72 (mean age 53.4), were treated with bipolar RF SECTUM, vaginal and vulvar application, as well as with a hyaluronic acid (HA) injection into the skin of the labia majora. The Vaginal Laxity Questionnaire (VLQ), Vaginal Health Index (VHI), and Female Sexual Function Index (FSFI) were used to examine the clinical effects of the operations. The Global Aesthetic Improvement Scale was utilized to measure patient satisfaction. On a histochemical level, the concentrations of elastin and collagen in the vaginal wall and vulvar skin were examined. Results: There was significantly higher patient satisfaction and a considerable clinical improvement across all areas of analysis. On the histochemical level, elastin and collagen fiber concentration increased after the treatment protocol both in the vulvar skin and in the vaginal wall: elastin in the vaginal wall, 11.4%, and in the vulvar skin, 61%; collagen in the vaginal wall, 26%, and in the vulvar skin, 27%. The current study demonstrated the efficacy and safety of this nonsurgical RF procedure combined with a hyaluronic acid (HA) injection into the skin of the labia majora on clinical, histochemical, and aesthetic levels.
format Online
Article
Text
id pubmed-9788573
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97885732022-12-24 Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity Kolczewski, Piotr Parafiniuk, Mirosław Zawodny, Piotr Haddad, Rashad Nalewczyńska, Agnieszka Kolasa, Agnieszka Kinga Wiszniewska, Barbara Menkes, Sophie Bader, Alexander Stabile, Giorgio Zerbinati, Nicola Pharmaceuticals (Basel) Article Vaginal laxity (VL) and genitourinary syndrome of menopause (GSM), as well as aesthetic changes in the vulvar skin, often occur together and cause physical, psychological, and functional problems for women and their partners. The current study evaluated the efficacy of a nonsurgical radiofrequency device (RF) procedure combined with hyaluronic acid (HA) injection into the skin of the labia majora on clinical, histological, and aesthetic levels. Twenty women with GSM and VL, aged between 36 and 72 (mean age 53.4), were treated with bipolar RF SECTUM, vaginal and vulvar application, as well as with a hyaluronic acid (HA) injection into the skin of the labia majora. The Vaginal Laxity Questionnaire (VLQ), Vaginal Health Index (VHI), and Female Sexual Function Index (FSFI) were used to examine the clinical effects of the operations. The Global Aesthetic Improvement Scale was utilized to measure patient satisfaction. On a histochemical level, the concentrations of elastin and collagen in the vaginal wall and vulvar skin were examined. Results: There was significantly higher patient satisfaction and a considerable clinical improvement across all areas of analysis. On the histochemical level, elastin and collagen fiber concentration increased after the treatment protocol both in the vulvar skin and in the vaginal wall: elastin in the vaginal wall, 11.4%, and in the vulvar skin, 61%; collagen in the vaginal wall, 26%, and in the vulvar skin, 27%. The current study demonstrated the efficacy and safety of this nonsurgical RF procedure combined with a hyaluronic acid (HA) injection into the skin of the labia majora on clinical, histochemical, and aesthetic levels. MDPI 2022-12-16 /pmc/articles/PMC9788573/ /pubmed/36559022 http://dx.doi.org/10.3390/ph15121571 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kolczewski, Piotr
Parafiniuk, Mirosław
Zawodny, Piotr
Haddad, Rashad
Nalewczyńska, Agnieszka
Kolasa, Agnieszka Kinga
Wiszniewska, Barbara
Menkes, Sophie
Bader, Alexander
Stabile, Giorgio
Zerbinati, Nicola
Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
title Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
title_full Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
title_fullStr Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
title_full_unstemmed Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
title_short Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
title_sort hyaluronic acid and radiofrequency in patients with urogenital atrophy and vaginal laxity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788573/
https://www.ncbi.nlm.nih.gov/pubmed/36559022
http://dx.doi.org/10.3390/ph15121571
work_keys_str_mv AT kolczewskipiotr hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT parafiniukmirosław hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT zawodnypiotr hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT haddadrashad hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT nalewczynskaagnieszka hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT kolasaagnieszkakinga hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT wiszniewskabarbara hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT menkessophie hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT baderalexander hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT stabilegiorgio hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity
AT zerbinatinicola hyaluronicacidandradiofrequencyinpatientswithurogenitalatrophyandvaginallaxity